Syngeneic mouse model choose Syngeneic mouse model, its Pha,PharmaLegacy_specification/price/image

Product Detail
Company Profile

PharmaLegacy Laboratories (Shanghai) Co., Ltdis a Syngeneic mouse model,Syngeneic mouse modelin one large multi-functional integrated modern enterprise,and devote the high-quality Respiratory Disease Model and first-class service for the masses of customers.

PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Immunotherapeutics fight cancer by taking advantage of a patient's own immune system, therefore, preclinical research into new therapies requires appropriate models with fully functional immunity. Syngeneic mouse model (allografts derived from immortalized mouse cancer cell lines which originated from the same inbred strain of mice) provide a valuable system for assessing new single agent, combination immunotherapies, or combination radiotherapy within mice with fully competent immunity. Pharmalegacy provides a panel of well validated syngeneic mouse models for preclinical immunotherapy research, used to interrogating novel immune-oncology treatments via activating the mouse immune system. We have model types include subcutaneous, orthotopic and metastatic. Our suite of syngeneic mouse model includes 22 models covering 14 cancer types and more on going, which validated with anti-PD-1, PD-L1 and anti-CTLA-4 antibodies

Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacyRespiratory Disease Modelx2a38631n, please visit our official website: www.pharmalegacy.com.

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings